More Globe Newswire

View Older Stories View Newer Stories

Nov 4, 2024 08:00AM Lifeward Streamlines U.S. Operations in Next Phase of Growth and Operational Efficiencies
Nov 4, 2024 08:00AM FOREWARN Partners with Triad Multiple Listing Service
Nov 4, 2024 08:00AM “Share Your Purple Power” This November in Honor of National Epilepsy Awareness Month
Nov 4, 2024 08:00AM InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services
Nov 4, 2024 08:00AM Ambassador Blackbird Wins Best in API Coding/Design Tools
Nov 4, 2024 08:00AM Whitestone REIT Continues Board Refreshment with Appointment of Two Independent Trustees
Nov 4, 2024 08:00AM Alignment Healthcare to Present at UBS Global Healthcare Conference and Stephens Annual Investment Conference
Nov 4, 2024 08:00AM Hopebridge expands access to higher education through university partnerships
Nov 4, 2024 08:00AM Janover Enters Licensing Agreement with Leading Commercial Real Estate Services Firm to Provide AI Client Engagement Tools
Nov 4, 2024 08:00AM ALX Oncology Announces November Investor Conference Participation
Nov 4, 2024 08:00AM MIMEDX to Participate in Upcoming Investor Conferences
Nov 4, 2024 08:00AM Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024
Nov 4, 2024 08:00AM BairesDev Named a 2024 Power Partner Award Winner by Inc.
Nov 4, 2024 08:00AM STMicroelectronics Announces Status of Common Share Repurchase Program
Nov 4, 2024 08:00AM 4BIO Capital Strengthens Investment Team
Nov 4, 2024 08:00AM Notice on Convocation of Extraordinary General Meeting of Shareholders of AB “KN Energies”
Nov 4, 2024 07:50AM BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13
Nov 4, 2024 07:50AM Purple Biotech Identifies Potential New Serum Biomarker for its Lead Oncology Therapeutic Candidate CM24: Associated with 79% Reduction in Risk of Death
Nov 4, 2024 07:50AM Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval
Nov 4, 2024 07:45AM Regenx Announces Facility Update
Nov 4, 2024 07:38AM Bitget Wallet Lite Hits 6 Million Users in Days, Now The Largest Telegram Wallet
Nov 4, 2024 07:35AM Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in Japan
Nov 4, 2024 07:30AM FTI Consulting Expands Financial Services Practice with Appointment of Two Senior Managing Directors
Nov 4, 2024 07:30AM Aveanna Healthcare Holdings Announces Appointment of New Director
Nov 4, 2024 07:30AM Apogee Therapeutics to Participate in Upcoming November Investor Conferences
Nov 4, 2024 07:30AM Altimmune to Report Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024
Nov 4, 2024 07:30AM Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
Nov 4, 2024 07:30AM Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Nov 4, 2024 07:30AM Emergent BioSolutions Appoints Dr. Simon Lowry as Chief Medical Officer and Head of Research and Development
Nov 4, 2024 07:30AM ZenaTech Announces Dual Listing of Its Shares on the Frankfurt Stock Exchange
Nov 4, 2024 07:30AM Legend Biotech Appoints Alan Bash as President of CARVYKTI®
Nov 4, 2024 07:30AM Scorpius Holdings Announces Collaboration with Celltheon Corporation, a U.S.-Based Cell Line Development Company; First Client Signed Under New Partnership Agreement
Nov 4, 2024 07:30AM Skyharbour Enters into Agreements to Partner with Hatchet Uranium Corp. on Several of its Uranium Projects Located in the Athabasca Basin, Saskatchewan
Nov 4, 2024 07:30AM Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
Nov 4, 2024 07:30AM Editas Medicine Announces Third Quarter 2024 Results and Business Updates
Nov 4, 2024 07:30AM SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results
Nov 4, 2024 07:30AM Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care
Nov 4, 2024 07:30AM Abeona Therapeutics® Announces Participation in November Investor Conferences
Nov 4, 2024 07:30AM Finance Expert Shinobu Hindert Leads Financial Literacy Workshop in Kenya to Empower Young Women
Nov 4, 2024 07:30AM Incyclix Bio Announces Abstract Accepted for Presentation at 2024 San Antonio Breast Cancer Symposium
Nov 4, 2024 07:30AM ElevateBio Appoints Amy Pooler, Ph.D., as Senior Vice President, Research and Development
Nov 4, 2024 07:25AM Korro Announces Regulatory Filing for Initiation of KRRO-110 First-In-Human Study and Formation of Clinical Advisory Board
Nov 4, 2024 07:20AM Trading by management and close relations of management
Nov 4, 2024 07:20AM Keynode Introduces Innovative Free Crypto Staking Plan, Empowering Users to Earn Passive Income
Nov 4, 2024 07:18AM Form 8.3 - [ECKOH PLC - 01 11 2024] - (CGWL)
Nov 4, 2024 07:17AM Ward Village® Welcomes Residents to Victoria Place® as Newest Residential Tower Opens in Acclaimed Howard Hughes Community in Honolulu
Nov 4, 2024 07:11AM FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
Nov 4, 2024 07:08AM Can-Fite anti-Obesity Drug Namodenoson Received Patent Allowance in Australia
Nov 4, 2024 07:05AM Kraig Biocraft Laboratories Announces Successful Completion of Latest Recombinant Spider Silk Production Batch
Nov 4, 2024 07:05AM Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors
View Newer Stories View Older Stories